The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong
- PMID: 29134963
- DOI: 10.1038/ajg.2017.420
The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong
Comment in
-
Who is wrong? Responses to Kwo et al.Am J Gastroenterol. 2018 May;113(5):779-780. doi: 10.1038/s41395-018-0029-4. Epub 2018 Feb 27. Am J Gastroenterol. 2018. PMID: 29487409 No abstract available.
-
DAAs and long-term clinical outcome in hepatitis C: the panacea for all diseases still does not exist.Am J Gastroenterol. 2018 Aug;113(8):1251. doi: 10.1038/s41395-018-0062-3. Am J Gastroenterol. 2018. PMID: 29686274 No abstract available.
-
Response to Perrella et al.Am J Gastroenterol. 2018 Aug;113(8):1251-1252. doi: 10.1038/s41395-018-0166-9. Epub 2018 Jun 19. Am J Gastroenterol. 2018. PMID: 29915397 No abstract available.
Comment on
-
Direct-acting antivirals for chronic hepatitis C.Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3. Cochrane Database Syst Rev. 2017. PMID: 28922704 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical